Guideline

Southern African HIV Clinicians Society guideline on pre-exposure prophylaxis to prevent HIV

Pippa Macdonald, Gonasagrie Nair, Camilla Wattrus, Saiqa Mullick, Melanie Pleaner, Elzette Rousseau, Hasina Subedar, Dvora Joseph-Davey, Johan Hugo, Sinead Delany-Moretlwe, Linda-Gail Bekker
Southern African Journal of HIV Medicine | Vol 26, No 1 | a1713 | DOI: https://doi.org/10.4102/sajhivmed.v26i1.1713 | © 2025 Pippa Macdonald, Gonasagrie Nair, Camilla Wattrus, Saiqa Mullick, Melanie Pleaner, Elzette Rousseau, Hasina Subedar, Dvora Joseph-Davey, Johan Hugo, Sinead Delany-Moretlwe, Linda-Gail Bekker | This work is licensed under CC Attribution 4.0
Submitted: 18 February 2025 | Published: 11 April 2025

About the author(s)

Pippa Macdonald, The Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
Gonasagrie Nair, The Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
Camilla Wattrus, Southern African HIV Clinicians Society (SAHCS), Johannesburg, South Africa
Saiqa Mullick, Wits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Melanie Pleaner, Wits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Elzette Rousseau, The Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
Hasina Subedar, National Department of Health, Pretoria, South Africa
Dvora Joseph-Davey, Division of Infectious Diseases, University of California Los Angeles, Los Angeles, United States of America; and, Department of Epidemiology and Biostatistics, University of Cape Town, South Africa
Johan Hugo, Anova Health Institute, Cape Town, South Africa
Sinead Delany-Moretlwe, Wits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Linda-Gail Bekker, The Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa

Abstract

No Abstract available.

Keywords

pre-exposure prophylaxis; PrEP; HIV; HIV prevention; dapivirine; cabotegravir; DVR; CAB-LA; oral PrEP; prevention

Metrics

Total abstract views: 1948
Total article views: 6372

 

Crossref Citations

1. I needed somebody to encourage me to take it [PrEP], maybe it would have protected me and the baby: a qualitative study to understand prenatal oral PrEP use among pregnant adolescent girls and young women in Tshwane, South Africa
Jacqueline W. Ndirangu, Wendee M. Wechsberg, Felicia A. Browne, Courtney P. Bonner, Alexandra M. Minnis, Laura Nyblade, Ilene S. Speizer, Brittni N. Howard, Poonam Rawat, Khatija Ahmed
Reproductive Health  vol: 22  issue: 1  year: 2025  
doi: 10.1186/s12978-025-02151-6

2. Willingness to switch to injectable cabotegravir among oral PrEP users in Durban, South Africa
Tanuja N. Gengiah, Vaishnavi Naidoo, Nothile Dlamini, Maseeha Khan, Snenhlahla S. Khanyile, Sithuthukile P. Nxumalo, Minenhle L. Sithole, Azraa Sultan, Felix Made
Health SA Gesondheid  year: 2025  
doi: 10.4102/HSAG.v30i0.3120

3. South African harm reduction guideline for chemsex
Andrew Scheibe, Yolaan Andrews, Ben Brown, Naeem Cassim, Thato Chidarikire, Johan Hugo, Regina Maithufi, Sive Mjindi, Dawie Nel, Shaun Shelly, Jabulile Sibeko, Mariette Slabbert, Londeka Xulu, Antons Mozalevskis
Southern African Journal of HIV Medicine  vol: 26  issue: 1  year: 2025  
doi: 10.4102/sajhivmed.v26i1.1763